Her2-negative Archives - European Biotechnology Magazine

Tag Archive for: Her2-negative

Roche presents details on breast cancer pill giredestrant

Roche has unveiled detailed data for its oral selective estrogen receptor degrader (SERD), giredestrant, at the 2025 San Antonio Breast Cancer Symposium.

12 December 2025

Roche presents details on breast cancer pill giredestrant

Genmab and AbbVie’s epcoritamab fails in phase 3...

Genethon licenses core AB-1009 technology to AskBio...

EMA and FDA join forces: Aligned principles on AI u...

SFDA vs EMA: What Biotech Leaders need to Know

Stay up to date every week with the european biotechnology newsletter.

Stay up to date every week with the european biotechnology newsletter.

Tag Archive for: Her2-negative